John J. Acton

566 total citations
18 papers, 409 citations indexed

About

John J. Acton is a scholar working on Molecular Biology, Organic Chemistry and Physiology. According to data from OpenAlex, John J. Acton has authored 18 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Organic Chemistry and 6 papers in Physiology. Recurrent topics in John J. Acton's work include Peroxisome Proliferator-Activated Receptors (4 papers), Chemical Synthesis and Analysis (3 papers) and Adipose Tissue and Metabolism (3 papers). John J. Acton is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (4 papers), Chemical Synthesis and Analysis (3 papers) and Adipose Tissue and Metabolism (3 papers). John J. Acton collaborates with scholars based in United States and Canada. John J. Acton's co-authors include A. Brian Jones, Thomas W. Doebber, Harold B. Wood, Lawrence F. Colwell, Joel P. Berger, David E. Moller, Regina M. Black, Ronald Melzack, Karen L. MacNaul and John E. McKenna and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Medicinal Chemistry and Experimental Neurology.

In The Last Decade

John J. Acton

17 papers receiving 380 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John J. Acton United States 10 282 106 66 63 61 18 409
A K Okwu United States 8 204 0.7× 82 0.8× 94 1.4× 34 0.5× 41 0.7× 8 358
Denise Wilcox United States 11 239 0.8× 82 0.8× 68 1.0× 57 0.9× 18 0.3× 18 472
Sergio Porté Spain 16 361 1.3× 48 0.5× 66 1.0× 52 0.8× 20 0.3× 23 637
Pushkaraj J. Lad United States 12 240 0.9× 105 1.0× 37 0.6× 23 0.4× 27 0.4× 23 440
Roxane Mansouri France 11 270 1.0× 79 0.7× 74 1.1× 32 0.5× 36 0.6× 13 445
Claudette Mookherjee United Kingdom 6 210 0.7× 70 0.7× 26 0.4× 40 0.6× 35 0.6× 7 286
David M. Guido United States 12 180 0.6× 77 0.7× 21 0.3× 35 0.6× 23 0.4× 14 456
Ulla Karlsson Sweden 6 370 1.3× 70 0.7× 75 1.1× 23 0.4× 26 0.4× 7 458
Hirotoshi Kakuta Japan 14 221 0.8× 44 0.4× 42 0.6× 42 0.7× 23 0.4× 25 531
Ving G. Lee United States 10 288 1.0× 271 2.6× 30 0.5× 103 1.6× 39 0.6× 15 527

Countries citing papers authored by John J. Acton

Since Specialization
Citations

This map shows the geographic impact of John J. Acton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John J. Acton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John J. Acton more than expected).

Fields of papers citing papers by John J. Acton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John J. Acton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John J. Acton. The network helps show where John J. Acton may publish in the future.

Co-authorship network of co-authors of John J. Acton

This figure shows the co-authorship network connecting the top 25 collaborators of John J. Acton. A scholar is included among the top collaborators of John J. Acton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John J. Acton. John J. Acton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Szewczyk, Jason W., John J. Acton, Alan D. Adams, et al.. (2010). Design of potent and selective GPR119 agonists for type II diabetes. Bioorganic & Medicinal Chemistry Letters. 21(9). 2665–2669. 21 indexed citations
3.
4.
Liu, Kun, Regina M. Black, John J. Acton, et al.. (2005). Selective PPARγ modulators with improved pharmacological profiles. Bioorganic & Medicinal Chemistry Letters. 15(10). 2437–2440. 56 indexed citations
5.
Acton, John J., Regina M. Black, A. Brian Jones, et al.. (2004). Benzoyl 2-methyl indoles as selective PPARγ modulators. Bioorganic & Medicinal Chemistry Letters. 15(2). 357–362. 105 indexed citations
6.
Jones, A. Brian, John J. Acton, Richard Cummings, et al.. (1999). Tetrapeptide derived inhibitors of complexation of a class II MHC: the peptide backbone is not inviolate. Bioorganic & Medicinal Chemistry Letters. 9(14). 2109–2114. 3 indexed citations
7.
Jones, A. Brian, John J. Acton, Alan D. Adams, et al.. (1999). Tetrapeptide derived inhibitors of complexation of a class II MHC: fully unnatural ligands. Bioorganic & Medicinal Chemistry Letters. 9(14). 2115–2118. 3 indexed citations
8.
Acton, John J. & A. Brian Jones. (1996). Synthesis and derivatization of a versatile α-substituted lactam dipeptide isostere. Tetrahedron Letters. 37(25). 4319–4322. 12 indexed citations
9.
10.
Biftu, Tesfaye, John J. Acton, Gregory D. Berger, et al.. (1994). Selective Protection and Relative Importance of the Carboxylic Acid Groups of Zaragozic Acid A for Squalene Synthase Inhibition. Journal of Medicinal Chemistry. 37(3). 421–424. 19 indexed citations
11.
Biftu, Tesfaye, John J. Acton, Gregory D. Berger, et al.. (1994). ChemInform Abstract: Selective Protection and Relative Importance of the Carboxylic Acid Groups of Zargozic Acid A for Squalene Synthase Inhibition.. ChemInform. 25(23). 1 indexed citations
12.
Jones, A. Brian, John J. Acton, & George A. Doss. (1993). Selectivity in the dehydration of 15-membered azalides. Tetrahedron Letters. 34(31). 4913–4916. 3 indexed citations
13.
Acton, John J., John E. McKenna, & Ronald Melzack. (1992). Amitriptyline produces analgesia in the formalin pain test. Experimental Neurology. 117(1). 94–96. 45 indexed citations
14.
15.
Sahoo, Soumya P., Donald W. Graham, John J. Acton, et al.. (1991). Synthesis and biological activity of MK 287 (L-680,573): a potent, specific and orally active paf receptor antagonist. Bioorganic & Medicinal Chemistry Letters. 1(6). 327–332. 13 indexed citations
16.
Biftu, Tesfaye, et al.. (1989). 2,5-Diaryltetrahydrofurans: PAF antagonists. Drugs of the Future. 14(4). 359–359. 4 indexed citations
17.
Ponpipom, Mitree M., San-Bao Hwang, Thomas W. Doebber, et al.. (1988). (±)- Trans -2-(3-methoxy-5-methylsulfonyl-4-propoxyphenyl)-5-(3,4,5-trimethoxyphenyl)tetrahydrofuran (L-659,989), a novel, potent PAF receptor antagonist. Biochemical and Biophysical Research Communications. 150(3). 1213–1220. 49 indexed citations
18.
Biftu, Tesfaye, John C. Chabala, John J. Acton, et al.. (1988). Synthesis and structure-activity relationship of 2,5-diaryltetrahydrofurans as PAF antagonists. Prostaglandins. 35(5). 846–846. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A K Okwu Breakdown of academic impact, for papers by Denise Wilcox Breakdown of academic impact, for papers by Sergio Porté Breakdown of academic impact, for papers by Pushkaraj J. Lad Breakdown of academic impact, for papers by Roxane Mansouri Breakdown of academic impact, for papers by Claudette Mookherjee Breakdown of academic impact, for papers by David M. Guido Breakdown of academic impact, for papers by Ulla Karlsson Breakdown of academic impact, for papers by Hirotoshi Kakuta Breakdown of academic impact, for papers by Ving G. Lee
Rankless by CCL
2026